Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2009
10/22/2009WO2009127615A1 Novel imidazole derivatives having microbiocidal activity
10/22/2009WO2009127546A1 Pyrrolidinone glucokinase activators
10/22/2009WO2009127544A1 Pyridazinone glucokinase activators
10/22/2009WO2009102428A3 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
10/22/2009US20090264655 Intermediates to HCV inhibitors; One pot borylation/Suzuki coupling process
10/22/2009US20090264654 Process for the preparation of pyrimidine compounds
10/22/2009US20090264653 Useful indole compounds
10/22/2009US20090264649 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
10/22/2009US20090264647 Benzoimidazole compounds
10/22/2009US20090264646 Benzoimidazole compounds
10/22/2009US20090264645 Benzoimidazole compounds
10/22/2009US20090264462 Kappa opioid receptor ligands
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264447 Pyrimidine compounds for combating pathogenic fungi and cancer
10/22/2009US20090264446 Condensed Pyridines as Kinase Inhibitors
10/22/2009US20090264445 (S)-3-Cyclopentyl-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionamide, useful for the treatment of metabolic disorders such as non-insulin dependent diabetes; antidiabetic agents
10/22/2009US20090264442 Pyrazole derivatives as sigma receptor inhibitors
10/22/2009US20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264425 Chemical compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090264417 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090264402 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090264315 Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof
10/22/2009US20090263472 Endothelin receptor antagonist derivatives
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2720943A1 Novel polymorphic forms of sunitinib base
10/22/2009CA2720559A1 Pyridazinone glucokinase activators
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/21/2009EP2110376A1 Novel compounds for electronic material and organic electronic device using the same
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1708997B1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1463506B1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563330A Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
10/21/2009CN101560204A Antihypertensive drug cilazapril intermediate and preparation method thereof
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/20/2009US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009US7605272 N-{2-[2-(1H-indazol-3-yl)vinyl]-5-(4-methylpiperazin-1-ylmethyl)phenyl}-3-methylthiophene-2-carboxamide; type I insulin-like growth factor receptor inhibitors; anticarcinognenic agents; colon, pancreatic cancers; antitumor agents; hematopoietic tumors; industrial scale
10/20/2009US7605264 Nitrogen-containing tetracylic bridged ring compounds; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
10/20/2009US7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605160 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605111 Herbicides
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2368843C Neurotrophic substituted pyrimidines
10/15/2009WO2009126947A2 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
10/15/2009WO2009126863A2 Pyridyl inhibitors of hedgehog signalling
10/15/2009WO2009126675A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009WO2009126672A2 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009126315A2 Macrocyclic compounds and methods of treatment
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125365A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/15/2009WO2009124903A1 Substituted pyridazinylmethyl sulfonamides
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009095712A3 4-(3-amin0pyraz0le) pyrimidine derivatives for use as jak kinase inhibitors in the treatment of cancer
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258892 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258876 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009US20090258862 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090256468 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2725398A1 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
10/15/2009CA2725395A1 Pyridyl inhibitors of hedgehog signalling
10/15/2009CA2721163A1 Macrocyclic compounds and methods of treatment
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009CA2719569A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/15/2009CA2718770A1 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108012A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 626